Successful treatment of paraneoplastic cerebellar degeneration with Rituximab.
Esposito
Marcello
M
Penza
P
P
Orefice
G
G
Pagano
A
A
Parente
E
E
Abbadessa
A
A
Bonavita
V
V
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008875:Middle Aged; D020362:Paraneoplastic Cerebellar Degeneration / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab